Literature DB >> 22626832

Citrullinated mouse collagen administered to DBA/1J mice in the absence of adjuvant initiates arthritis.

Geoffrey M Thiele1, Michael J Duryee, Anand Dusad, Carlos D Hunter, Jordan P Lacy, Daniel R Anderson, Dong Wang, James R O'Dell, Ted R Mikuls, Lynell W Klassen.   

Abstract

INTRODUCTION: Citrullinated self-proteins are thought to be involved in the onset/progression of rheumatoid arthritis (RA). Numerous studies have been performed to look for the self-antigen that becomes citrullinated and induces RA. Importantly, these studies have been performed using citrullinated self-antigens injected into an animal model in the presence of a strong adjuvant in order to derive the response. However, to date no studies have been performed to determine if these phenotypes can be induced in the absence of an adjuvant.
METHODS: To investigate this possibility, mice were immunized with citrullinated or non-citrullinated mouse Type II collagen (Cit-Col or Col) in the presence or absence of Freund's Complete Adjuvant (FCA).
RESULTS: An autoimmune-like RA response was observed in mice immunized with Cit-Col in the absence of FCA; by the increase in caliper score, visual observation, and micro-CT analysis of bone erosions. Antibody and T-cell responses were increased in the Cit-Col injected mice to Cit-Col as well as antibody to Anti-Citrullinated Peptide Antigens (ACPA) as determined by a commercially available test kit.
CONCLUSIONS: Therefore, the use of citrullinated mouse collagen induces an autoimmune-like RA in the absence of an adjuvant. These data also suggest that citrullinate self-proteins may be potential molecular adjuvants that assist in driving an inflammatory response, that increases the production of PAD in joint tissue, resulting in the citrullination of other self-proteins to exacerbate the disease.
Copyright © 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22626832     DOI: 10.1016/j.intimp.2012.05.007

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  15 in total

1.  Autoantibodies From Single Circulating Plasmablasts React With Citrullinated Antigens and Porphyromonas gingivalis in Rheumatoid Arthritis.

Authors:  Song Li; Yangsheng Yu; Yinshi Yue; Hongyan Liao; Wanqin Xie; Jessica Thai; Ted R Mikuls; Geoffrey M Thiele; Michael J Duryee; Harlan Sayles; Jeffrey B Payne; Lynell W Klassen; James R O'Dell; Zhixin Zhang; Kaihong Su
Journal:  Arthritis Rheumatol       Date:  2016-03       Impact factor: 10.995

Review 2.  Rheumatoid arthritis vaccine therapies: perspectives and lessons from therapeutic ligand epitope antigen presentation system vaccines for models of rheumatoid arthritis.

Authors:  Kenneth S Rosenthal; Katalin Mikecz; Harold L Steiner; Tibor T Glant; Alison Finnegan; Roy E Carambula; Daniel H Zimmerman
Journal:  Expert Rev Vaccines       Date:  2015-03-18       Impact factor: 5.217

3.  Combined Collagen-Induced Arthritis and Organic Dust-Induced Airway Inflammation to Model Inflammatory Lung Disease in Rheumatoid Arthritis.

Authors:  Jill A Poole; Geoffrey M Thiele; Katherine Janike; Amy J Nelson; Michael J Duryee; Kathryn Rentfro; Bryant R England; Debra J Romberger; Joseph M Carrington; Dong Wang; Benjamin J Swanson; Lynell W Klassen; Ted R Mikuls
Journal:  J Bone Miner Res       Date:  2019-06-24       Impact factor: 6.741

4.  The impact of airborne endotoxin exposure on rheumatoid arthritis-related joint damage, autoantigen expression, autoimmunity, and lung disease.

Authors:  Ted R Mikuls; Rohit Gaurav; Geoffrey M Thiele; Bryant R England; Madison G Wolfe; Brianna P Shaw; Kristina L Bailey; Todd A Wyatt; Amy J Nelson; Michael J Duryee; Carlos D Hunter; Dong Wang; Debra J Romberger; Dana P Ascherman; Jill A Poole
Journal:  Int Immunopharmacol       Date:  2021-08-27       Impact factor: 4.932

Review 5.  Autoimmunity to citrullinated proteins and the initiation of rheumatoid arthritis.

Authors:  V Michael Holers
Journal:  Curr Opin Immunol       Date:  2013-11-08       Impact factor: 7.486

6.  Immunogenic and inflammatory responses to citrullinated proteins are enhanced following modification with malondialdehyde-acetaldehyde adducts.

Authors:  Geoffrey M Thiele; Michael J Duryee; Carlos D Hunter; Bryant R England; Benjamin S Fletcher; Eric C Daubach; Taylor P Pospisil; Lynell W Klassen; Ted R Mikuls
Journal:  Int Immunopharmacol       Date:  2020-03-27       Impact factor: 4.932

7.  Induction of bone loss in DBA/1J mice immunized with citrullinated autologous mouse type II collagen in the absence of adjuvant.

Authors:  Anand Dusad; Michael J Duryee; Anita T Shaw; Lynell W Klassen; Daniel R Anderson; Dong Wang; Ke Ren; Ellen M Gravallese; James R O'Dell; Ted R Mikuls; Geoffrey M Thiele
Journal:  Immunol Res       Date:  2014-01       Impact factor: 2.829

8.  Porphyromonas gingivalis peptidylarginine deiminase, a key contributor in the pathogenesis of experimental periodontal disease and experimental arthritis.

Authors:  Neville Gully; Richard Bright; Victor Marino; Ceilidh Marchant; Melissa Cantley; David Haynes; Catherine Butler; Stuart Dashper; Eric Reynolds; Mark Bartold
Journal:  PLoS One       Date:  2014-06-24       Impact factor: 3.240

9.  Development of synthetic anti-cyclic citrullinated peptide antibody and its arthritogenic role.

Authors:  Youngkyun Kim; Jennifer Lee; Hyerin Jung; Hyoju Yi; Yeri Alice Rim; Seung Min Jung; Ji Hyeon Ju
Journal:  Clin Transl Immunology       Date:  2015-11-27

10.  The Prerequisites for Central Tolerance Induction against Citrullinated Proteins in the Mouse.

Authors:  Robby Engelmann; Andra Biemelt; Antje Cordshagen; Anja Johl; Daniela Kuthning; Brigitte Müller-Hilke
Journal:  PLoS One       Date:  2016-06-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.